Try our Advanced Search for more refined results
December 15, 2014
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG et al v. TEVA PHARMACEUTICALS USA, INC. et al
Case Number:
3:14-cv-07811
Court:
Nature of Suit:
Judge:
Firms
Companies
- Alkem Laboratories Ltd.
- Apotex Inc.
- Boehringer Ingelheim Vetmedica Inc.
- Breckenridge Pharmaceutical Inc.
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
January 26, 2018
Mylan Pradaxa Generic Delayed In Boehringer Patent Deal
Mylan Pharmaceuticals Inc. has agreed to hold off on its generic version of Boehringer Ingelheim's blockbuster blood thinner Pradaxa as part of a patent infringement settlement cleared Friday by a New Jersey federal judge.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login